{"id":19921,"date":"2025-04-01T12:01:28","date_gmt":"2025-04-01T06:31:28","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=19921"},"modified":"2025-04-05T20:50:49","modified_gmt":"2025-04-05T15:20:49","slug":"alzheimers-disease","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/alzheimers-disease\/","title":{"rendered":"What is Alzheimer&#8217;s Disease?"},"content":{"rendered":"<h2>Alzheimer\u2019s Latest News<\/h2>\n<p>A new drug, Gantenerumab, shows promise in slowing early-onset Alzheimer\u2019s while significantly reducing amyloid plaque buildup, a key marker of the disease.<\/p>\n<h2>About Alzheimer\u2019s<\/h2>\n<ul>\n<li><strong>Alzheimer\u2019s disease is a progressive neurodegenerative disorder<\/strong> that primarily affects memory, thinking, and reasoning abilities.<\/li>\n<li>It is <strong>the most common cause of dementia<\/strong>, accounting for <strong>60-80% of all dementia cases<\/strong> worldwide.<\/li>\n<li>The disease <strong>disrupts communication between brain cells<\/strong>, leading to a decline in cognitive and functional abilities.<\/li>\n<\/ul>\n<h2>What is Early-Onset Alzheimer\u2019s?<\/h2>\n<ul>\n<li><strong>Most cases of Alzheimer\u2019s occur in individuals aged 65 or older<\/strong>, but around <strong>5-10% of cases develop before this age<\/strong>\u2014this is called <strong>Early-Onset Alzheimer\u2019s Disease (EOAD).<\/strong><\/li>\n<li>Unlike late-onset Alzheimer\u2019s, EOAD <strong>progresses more rapidly<\/strong> and <strong>often affects people in their prime working years<\/strong>, making it particularly devastating.<\/li>\n<li><strong>Genetic factors play a crucial role<\/strong> in early-onset cases, with mutations in three specific genes\u2014<strong>APP, PSEN1, and PSEN2<\/strong>\u2014linked to increased risk.<\/li>\n<li><strong>The Role of Amyloid Beta and Plaque Formation: The buildup of amyloid beta proteins in the brain<\/strong> leads to the formation of <strong>amyloid plaques<\/strong>, a hallmark of Alzheimer\u2019s disease.<\/li>\n<li>These plaques <strong>disrupt neural communication, trigger inflammation, and eventually lead to brain cell death.<\/strong><\/li>\n<li><strong>Amyloid-targeting therapies<\/strong> aim to reduce these plaques, potentially slowing disease progression.<\/li>\n<\/ul>\n<h2>About Gantenerumab<\/h2>\n<ul>\n<li><strong>Gantenerumab is an experimental drug<\/strong> that was initially discontinued but has now shown promise in new clinical trials.<\/li>\n<li>The <strong>latest trial<\/strong> focused on <strong>patients with genetic mutations<\/strong> known to cause early-onset Alzheimer\u2019s.<\/li>\n<li>It was a <strong>randomized, placebo-controlled study<\/strong>, tracking disease progression using <strong>brain imaging and blood biomarkers<\/strong>.<\/li>\n<li><strong>Results showed a significant reduction in amyloid plaque buildup<\/strong>, suggesting the drug may slow cognitive decline.<\/li>\n<\/ul>\n<h2>How Does Gantenerumab Work?<\/h2>\n<ul>\n<li><strong>It is a monoclonal antibody<\/strong>, meaning it is <strong>lab-engineered to specifically target amyloid beta proteins.<\/strong><\/li>\n<li>Once attached to amyloid plaques, it <strong>signals the immune system to break them down<\/strong> and remove them from the brain.<\/li>\n<li>The drug <strong>activates microglial cells<\/strong>, which act as the brain\u2019s <strong>primary immune defenders<\/strong>, to clear toxic proteins more efficiently.<\/li>\n<li>A major challenge in treating neurological diseases is the <strong>blood-brain barrier<\/strong>, which blocks many drugs from reaching the brain.<\/li>\n<li><strong>Gantenerumab can cross this barrier<\/strong>, making it more effective than some previous Alzheimer\u2019s treatments.<\/li>\n<\/ul>\n<h2>Alzheimer\u2019s FAQs<\/h2>\n<p><strong>Q1: <\/strong>What is Alzheimer\u2019s disease?<br \/>\n<strong>Ans:<\/strong> Alzheimer\u2019s is a neurodegenerative disorder that leads to progressive memory loss, cognitive decline, and behavioral changes due to brain cell damage.<\/p>\n<p><strong>Q2: <\/strong>What causes Alzheimer\u2019s disease?<br \/>\n<strong>Ans:<\/strong> The exact cause is unknown, but it is associated with the accumulation of beta-amyloid plaques and tau protein tangles in the brain, along with genetic and environmental factors.<\/p>\n<p><strong>Q3: <\/strong>What are the symptoms of Alzheimer\u2019s?<br \/>\n<strong>Ans:<\/strong> Early symptoms include memory loss, confusion, difficulty in problem-solving, and language impairment, which progressively worsen over time.<\/p>\n<p><strong>Q4:<\/strong> Is there a cure for Alzheimer\u2019s?<br \/>\n<strong>Ans:<\/strong> No, there is no cure yet, but medications like Donepezil and lifestyle modifications can help manage symptoms and slow disease progression.<\/p>\n<p><strong>Q5: <\/strong>How can Alzheimer\u2019s be prevented?<br \/>\n<strong>Ans:<\/strong> While prevention is not guaranteed, regular exercise, a healthy diet, mental stimulation, and social engagement may help reduce the risk of Alzheimer\u2019s.<\/p>\n<p><strong>Source: <\/strong><a href=\"https:\/\/www.downtoearth.org.in\/health\/early-onset-alzheimers-new-drug-shows-promise-in-slowing-the-disease\" target=\"_blank\" rel=\"nofollow noopener\">DTE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alzheimer&#8217;s Disease is a brain condition that causes a progressive decline in memory, thinking, learning, and organizing skills.<\/p>\n","protected":false},"author":5,"featured_media":19922,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-19921","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-upsc-prelims-current-affairs","8":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/19921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=19921"}],"version-history":[{"count":0,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/19921\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/19922"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=19921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=19921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=19921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}